Zuragen™ Clinic Poster
Local Article Example
Q & A
Educational Incentive Program
CRF Re-order Form
CRF Helpful Hints
Hemodialysis Catheter (Material) Types
Temperature Conversion Chart
AAT-023 Clinical Trial
Issue 2, October 4, 2006
A word from our Sponsor...
October in Indiana has brought much anticipation
this year. As with each autumn, we’ve looked forward to our
trees changing color, leaves dropping and the hope of Purdue’s
football team being a Big Ten powerhouse. However, this fall, the
beginning of our pivotal clinical trial eclipses all of these things.
While the months of July and August saw patient enrollment slowly
begin as the groundwork was being laid at each of your individual
sites, we are pleased to announce that enrollment doubled in the
month of September as six sites have now enrolled their 1st patient.
We look forward to having all of our sites participating in October
and seeing patient enrollment continue to rise.
As we stated in the PI / Coordinator Teleconference
earlier in September, we have set an aggressive goal to complete
enrollment by the end of this calendar year and appreciate all of
the hard work you are doing to make this a reality. Please let us
know how we can continue to support your efforts as well as what
tools and resources we could potentially develop to assist you in
Meet the Medical Monitors
Linda Francisco, MD
We are pleased to introduce Dr. Linda Francisco
as the Medical Monitor for the AAT-023 Trial. Dr. Francisco is
Board Certified in Nephrology and Internal Medicine, and practices
in the Wichita Nephrology Group (Wichita, KS) while serving as the
Medical Director for DaVita’s Wichita
Dialysis Center. She received her premedical education at the Universities
of Nebraska and Minnesota before completing her Medical Education,
Internship, Residency, and a Fellowship at the University of Iowa.
Dr. Francisco also serves as an Associate Professor of Medicine at
the University of Kansas School of Medicine and has authored works
for a variety of publications. When asked about her hobbies, she
get some, when I get the time!"
Monnie Wasse, MD, MPH
We are grateful to introduce Dr. Monnie Wasse
as our alternate Medical Monitor. Dr. Wasse, a native of Seattle,
completed her MPH and MD degrees at the University of Washington.
She is Board Certified in Nephrology and Internal Medicine, and is
an Assistant Professor of Medicine at Emory University in Atlanta,
Georgia, where she works as an interventional nephrologist, performing
endovascular procedures at the Dialysis Access Center of Atlanta.
Her research program is in the area of hemodialysis vascular access,
and is supported by the National Institues of Health and Robert Wood
Well, that’s how
Webster’s dictionary introduces the word but we have
learned that a member of our clinical trial team has taken
this definition to new heights. We were amazed to hear the
story of Heather Gunes-Peña, the Clinical
Coordinator at Dr. Hariachar’s site in Hudson, Florida.
When Heather found out that her honeymoon conflicted with her
NIH teleconference with WIRB, she changed
her wedding and honeymoon dates so she could be on the call! Wow, now that is dedication!
We are certainly not asking or expecting others to take dedication
to quite this level, but do feel fortunate to have many dedicated
people working on this study. Our best wishes for a lifetime
of good health and happiness to Heather and her husband, Gustavo,
in this very exciting time!
Committed to Growth & Development
Ash Access Technology
is excited about its newly–released Clinical Coordinator Educational
Incentive Program. Details of this exciting opportunity for your
site to earn funds for your staff’s professional development
were introduced through an email last week. Contact Rita DeVico
at email@example.com for more info.
|Dr. Hariachar, Hudson, FL
|Dr. Khwaja, Newport Beach, CA
|Dr. Kopelman, Bakersfield, CA
|Dr. Block, Denver, CO
|Dr. Rogers, Ocala, FL
|Dr. Al-Makki, Lafayette, IN
|Dr. Fadem, Houston, TX
|Dr. Henriquez, Bronx, NY
|Dr. Posner, Baltimore, MD
|Dr. Stephanz, Provo, UT
Monitor Phone Number: (765) 413-7676
All questions regarding
Inclusion/Exclusion criteria compliance, potential adverse
device effects, patient safety, and other medical issues related
to the study should be referred to the Medical Monitor.